Sagimet Biosciences Inc. Series A
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +517.9% | -14.4% | -44.0% | +192.8% | +65.7% | -27.3% | |
| – | +535.6% | -14.7% | -44.1% | +194.7% | +58.1% | -23.8% | |
| – | +572.8% | -17.4% | -99.7% | +47,456.3% | +0.9% | -53.8% | |
| – | +572.8% | -17.4% | -43.0% | +193.4% | +59.4% | -25.2% | |
| – | -39.0% | – | – | – | – | – | |
| – | +50.1% | +6.1% | +1.2% | -97.4% | -21.2% | +14.5% | |
| – | -8.0% | +27.7% | +116.4% | +7.1% | -21.2% | +14.5% | |
| – | +11.5% | -14.5% | +7.3% | -51.1% | +20.0% | +0.0% | |
| – | -57.2% | +48.3% | +47.8% | -83.5% | +666.1% | -8.1% | |
| – | – | – | – | – | +71.1% | -28.5% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | -17.9% | +72.3% | +3.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.